Turkey’s Mustafa Nevzat Attracts Seven MNCs Seeking Minority Interest
This article was originally published in PharmAsia News
Turkey’s Mustafa Nevzat Ilac has received acquisition proposals from seven multinational drug makers, including Pfizer and GlaxoSmithKline, offering to buy minority stakes.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.